December 28, 2014 11:41 AM ET

Capital Markets

Company Overview of Skyline Ventures

Executive Profile

Stephen J. Hoffman M.D., Ph.D.

Senior Advisor, PDL BioPharma, Inc.
AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 14 different industries.

See Board Relationships
60--

Background

Dr. Stephen J. Hoffman, also known as Steve, M.D., Ph.D., has been a Senior Advisor at BioPharma, Inc., since February 3, 2014. Dr. Hoffman served as the Managing Director of Skyline Ventures since joining in May 2007. Prior to joining Skyline, Dr. Hoffman served as a General Partner of TVM Capital GmbH from January 2003 to March 2007. He served as the General Partner of TVM V Life Science Ventures. He served as an Investment Manager in the Life Science team since January ...

Corporate Headquarters

525 University Avenue
Palo Alto, California 94301

United States

Phone: 650-462-5800
Fax: 650-329-1090

Board Members Memberships

Former Chairman
Former Director
Prior
Former Director
Director
Former Director
Director
Former Director
Former Director
Former Director
Former Director
1994-Present
Chairman, Chairman of Nominating & Corporate Governance Committee and Member of Audit Committee
2004-N/A
Director, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
2007-Present
Director, Chairman of Audit Committee and Member of Compensation Committee
2010-Present
Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee
2010-Present
Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee

Education

PhD
Northwestern University
MD
University of Colorado School of Medicine

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John W. Varian Chief Executive Officer, President and Director
XOMA Corporation
$489.3K
Michael S. O. Oredsson B.Int’l Bus Admin (Lund)Chief Executive Officer and President
BioInvent International AB
$735.0K
Jan G. J. van de Winkel Ph.D.Co-Founder, Chief Executive Officer and President
Genmab A/S
$10.7M
Tim Van Hauwermeiren MSc, EMBAChief Executive Officer and Director of Management Board
arGEN-X N.V
$256.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Skyline Ventures, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.